Dr Mark Soave

Mark completed his PhD (2017) at the University of Nottingham under the supervision of Prof Stephen Hill and Prof Jeanette Woolard where studied the molecular pharmacology of an antibody raised against the Beta-1 adrenoceptor. He continued his research in Nottingham, working with Prof Hill and Dr Stephen Briddon to investigate the molecular pharmacology of Class A G protein-coupled receptors (GPCRs) with biologics and resonance energy transfer techniques. For this work, Mark was awarded the Bill Bowman Prize Lectureship in 2020. Mark has organised several virtual conferences for Early Career Researchers (ECRs), promoting ECR engagement throughout COVID lockdown, and provided a platform for ECRs to showcase their research. In 2021, Mark moved to OMass Therapeutics where he now works as a Senior Scientist within the Pharmacology & Immunology group. Mark is also involved with the European Laboratory Research & Innovation Group (ELRIG), where he is Leader of the Early Career Professional Workgroup and an ELRIG Board Member.